OMDA

MKT CAP:$845M

Omada Health

Market Cap

$845M

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$14.38-$0.52 (-3.48%)

Apr 23, 2026

Company Details

Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.

CEO

Sean Duffy

IPO Date

Jun 6, 2025

Website

www.omadahealth.com

Key Metrics TTM

Revenue

$232M

+50.5% YoY

Net Income

-$26M

EPS (Diluted)

-$0.47

Free Cash Flow

-$13M

Revenue / Share

$4.03

Gross Margin

64.2%

Operating Margin

-9.6%

Net Margin

-11.3%

FCF Margin

-5.4%

P/S

3.6x

P/E

—

Earnings Reports

FY 2025

Mar 6, 2026

$260M+53.2%EPS -$0.22

Q3 2025

Nov 7, 2025

$68M+49.5%EPS -$0.05

Q2 2025

Aug 8, 2025

$61M+48.9%EPS -$0.09

Q1 2025

Mar 31, 2025

$55M+56.6%EPS -$0.17

FY 2024

Dec 31, 2024

$170M+38.3%EPS -$0.85

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 23	$33M	$20M	-$14M
Q4 23	$33M	$20M	-$13M
Q1 24	$35M	$17M	-$18M
Q2 24	$41M	$25M	-$10M
Q3 24	$46M	$28M	-$9M
Q4 24	$48M	$32M	-$7M
Q1 25	$55M	$32M	-$8M
Q2 25	$61M	$40M	-$4M
Q3 25	$68M	$45M	-$3M

Valuation

Quarter	P/S	P/E
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	8.9x	—
Q3 24	8.2x	—
Q4 24	7.4x	—
Q1 25	6.6x	—
Q2 25	4.9x	—
Q3 25	5.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 24	-$21M	-$21M
Q2 24	-$8M	-$9M
Q3 24	$1M	-$12.0K
Q4 24	-$6M	-$7M
Q1 25	-$16M	-$17M
Q2 25	$3M	$3M
Q3 25	$10M	$10M

Capital Expenditures

Quarter	CapEx
Q1 24	$781.0K
Q2 24	$1M
Q3 24	$1M
Q4 24	$969.0K
Q1 25	$1M
Q2 25	$271.0K
Q3 25	$537.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 24	+38.2%	+15.2%
Q4 24	+47.4%	+19.9%
Q1 25	+56.6%	+19.3%
Q2 25	+48.9%	+28.2%
Q3 25	+49.5%	+30.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 24	$3M	8.2%
Q2 24	$2M	5.0%
Q3 24	$2M	4.7%
Q4 24	$2M	4.8%
Q1 25	$3M	5.2%
Q2 25	$3M	4.6%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q3 23	$8M	—	—	$26M
Q4 23	$8M	—	—	$25M
Q1 24	$9M	$9M	$17M	—
Q2 24	$9M	—	—	$26M
Q3 24	$9M	—	—	$28M
Q4 24	$9M	—	—	$30M
Q1 25	$9M	$11M	$20M	—
Q2 25	$10M	$12M	$22M	—
Q3 25	$10M	$14M	$23M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 24	$116M	$0	$116M
Q1 25	$59M	$0	$59M
Q2 25	$223M	$0	$223M
Q3 25	$199M	$0	$199M
Q4 25	$222M	$0	$222M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 23	56M	—	—
Q4 23	56M	0.0%	—
Q1 24	56M	0.0%	—
Q2 24	56M	0.0%	—
Q3 24	56M	0.0%	0.0%
Q4 24	56M	0.0%	0.0%
Q1 25	56M	0.0%	0.0%
Q2 25	57M	+2.8%	+2.8%
Q3 25	58M	+0.6%	+3.4%

Shares Outstanding